AAAAAA
Results:
1-18
|
Results: 18
Authors:
SHETYE J
RAGNHAMMAR P
LILJEFORS M
CHRISTENSSON B
FRODIN JE
BIBERFELD P
MELLSTEDT H
Citation: J. Shetye et al., IMMUNOPATHOLOGY OF METASTASES IN PATIENTS OF COLORECTAL-CARCINOMA TREATED WITH MONOCLONAL-ANTIBODY 17-1A AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR, Clinical cancer research, 4(8), 1998, pp. 1921-1929
Authors:
LILJEFORS M
FRODIN JE
SHETYE J
PORWIT A
RAGNHAMMAR P
SAMANCI A
WEGER A
MELLSTEDT H
Citation: M. Liljefors et al., EPITHELIAL-CELLS IN THE BONE-MARROW (BM) OF COLORECTAL-CARCINOMA (CRC) PATIENTS - A TOOL TO MONITOR IMMUNOTHERAPY, European journal of cancer, 33, 1997, pp. 386-386
Authors:
FRODIN JE
ERICSSON J
BARLOW L
Citation: Je. Frodin et al., MULTIPLE PRIMARY MALIGNANT-TUMORS IN A NATIONAL CANCER REGISTRY - RELIABILITY OF REPORTING, Acta oncologica, 36(5), 1997, pp. 465-469
Authors:
FAGERBERG J
RAGNHAMMAR P
LILJEFORS M
HJELM AL
MELLSTEDT H
FRODIN JE
Citation: J. Fagerberg et al., HUMORAL ANTIIDIOTYPIC AND ANTI-ANTI-IDIOTYPIC IMMUNE-RESPONSE IN CANCER-PATIENTS TREATED WITH MONOCLONAL-ANTIBODY 17-1A, Cancer immunology and immunotherapy, 42(2), 1996, pp. 81-87
Authors:
FRODIN JE
JONSSON E
MOLLER T
WERKO L
Citation: Je. Frodin et al., RADIOTHERAPY IN SWEDEN - A STUDY OF PRESENT USE IN RELATION TO THE LITERATURE AND AN ESTIMATE OF FUTURE-TRENDS, Acta oncologica, 35(8), 1996, pp. 967-979
Authors:
FRODIN JE
Citation: Je. Frodin, LUNG-CANCER, Acta oncologica, 35(7), 1996, pp. 46-53
Authors:
FRODIN JE
Citation: Je. Frodin, PROSTATE-CANCER, Acta oncologica, 35(7), 1996, pp. 70-74
MASS-SCREENING FOR PROSTATE-CANCER SBU - THE SWEDISH COUNCIL ON TECHNOLOGY-ASSESSMENT IN HEALTH-CARE
Authors:
JOHANSSON JE
ABRAHAMSSON PA
ADAMI HO
ADOLFSSON J
CARLSSON P
DAMBER JE
GUSTAVSSON O
HALLERBY N
LANDBERG T
MARKE LA
NORMING U
NYMAN CR
PONTEN J
RENTZHOG L
VANG J
WERKO L
JONSSON E
FRODIN JE
HERMEREN G
SVARDSUDD K
NORLEN BJ
PETTERSSON S
HOISAETER PA
GUSTAFSON R
Citation: Je. Johansson et al., MASS-SCREENING FOR PROSTATE-CANCER SBU - THE SWEDISH COUNCIL ON TECHNOLOGY-ASSESSMENT IN HEALTH-CARE, International journal of cancer, 1996, pp. 1-72
Authors:
HJELM AL
RAGNHAMMAR P
FAGERBERG J
MAGNUSSON I
FRODIN JE
SVANSTROM R
SHETYE J
MELLSTEDT H
WERSALL JP
Citation: Al. Hjelm et al., SUBCUTANEOUS INTERLEUKIN-2 AND ALPHA-INTERFERON IN ADVANCE COLORECTAL-CARCINOMA - A PHASE-II STUDY, Cancer biotherapy, 10(1), 1995, pp. 5-12
Authors:
RAGNHAMMAR P
FRODIN JE
HJELM AL
FAGERBERG J
WERSALL P
LINDEMALM C
NILSSON B
FOX K
MAGNUSSON I
EWERTH S
THOR K
SECHER E
MELLSTEDT H
Citation: P. Ragnhammar et al., DIFFERENT DOSE REGIMENS OF THE MOUSE MONOCLONAL-ANTIBODY 17-1A FOR THERAPY OF PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA, International journal of oncology, 7(5), 1995, pp. 1049-1056
Authors:
RAGNHAMMAR P
FAGERBERG J
FRODIN JE
WERSALL P
HANSSON LO
MELLSTEDT H
Citation: P. Ragnhammar et al., GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR AUGMENTS THE INDUCTION OF ANTIBODIES, ESPECIALLY ANTIIDIOTYPIC ANTIBODIES, TO THERAPEUTIC MONOCLONAL-ANTIBODIES, Cancer immunology and immunotherapy, 40(6), 1995, pp. 367-375
Authors:
FAGERBERG J
HJELM AL
RAGNHAMMAR P
FRODIN JE
WIGZELL H
MELLSTEDT H
Citation: J. Fagerberg et al., TUMOR-REGRESSION IN MONOCLONAL ANTIBODY-TREATED PATIENTS CORRELATES WITH THE PRESENCE OF ANTI-IDIOTYPE-REACTIVE T-LYMPHOCYTES, Cancer research, 55(9), 1995, pp. 1824-1827
Authors:
TANNERGARD P
LIPFORD JR
KOLODNER R
FRODIN JE
NORDENSKJOLD M
LINDBLOM A
Citation: P. Tannergard et al., MUTATION SCREENING IN THE HMLH1 GENE IN SWEDISH HEREDITARY NONPOLYPOSIS COLON-CANCER FAMILIES, Cancer research, 55(24), 1995, pp. 6092-6096
Authors:
RAGNHAMMAR P
FRODIN JE
TROTTA PP
MELLSTEDT H
Citation: P. Ragnhammar et al., CYTOTOXICITY OF WHITE BLOOD-CELLS ACTIVATED BY GRANULOCYTE-COLONY-STIMULATING FACTOR, GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR AND MACROPHAGE-COLONY-STIMULATING FACTOR AGAINST TUMOR-CELLS IN THE PRESENCE OF VARIOUS MONOCLONAL-ANTIBODIES/, Cancer immunology and immunotherapy, 39(4), 1994, pp. 254-262
Authors:
FAGERBERG J
FRODIN JE
RAGNHAMMAR P
STEINITZ M
WIGZELL H
MELLSTEDT H
Citation: J. Fagerberg et al., INDUCTION OF AN IMMUNE NETWORK CASCADE IN CANCER-PATIENTS TREATED WITH MONOCLONAL-ANTIBODIES (AB(1)) .2. IS INDUCTION OF ANTIIDIOTYPE REACTIVE T-CELLS (T-3) OF IMPORTANCE FOR TUMOR RESPONSE TO MAB THERAPY, Cancer immunology and immunotherapy, 38(3), 1994, pp. 149-159
Authors:
RAGNHAMMAR P
FRIESEN HJ
FRODIN JE
LEFVERT AK
HASSAN M
OSTERBORG A
MELLSTEDT H
Citation: P. Ragnhammar et al., INDUCTION OF ANTI-RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (ESCHERICHIA COLI-DERIVED) ANTIBODIES AND CLINICAL EFFECTS IN NONIMMUNOCOMPROMISED PATIENTS, Blood, 84(12), 1994, pp. 4078-4087
Authors:
WERSALL JP
MASUCCI G
HJELM AL
RAGNHAMMAR P
FAGERBERG J
FRODIN JE
MERK K
LINDEMALM C
ERICSON K
KALIN B
MELLSTEDT H
Citation: Jp. Wersall et al., LOW-DOSE CYCLOPHOSPHAMIDE, ALPHA-INTERFERON AND CONTINUOUS INFUSIONS OF INTERLEUKIN-2 IN ADVANCED RENAL-CELL CARCINOMA, Medical oncology and tumor pharmacotherapy, 10(3), 1993, pp. 103-111
Authors:
FAGERBERG J
FRODIN JE
WIGZELL H
MELLSTEDT H
Citation: J. Fagerberg et al., INDUCTION OF AN IMMUNE NETWORK CASCADE IN CANCER-PATIENTS TREATED WITH MONOCLONAL-ANTIBODIES (AB(1)) .1. MAY INDUCTION OF AB(1)-REACTIVE T-CELLS AND ANTI-ANTI-IDIOTYPIC ANTIBODIES (AB(3)) LEAD TO TUMOR-REGRESSION AFTER MAB THERAPY, Cancer immunology and immunotherapy, 37(4), 1993, pp. 264-270
Risultati:
1-18
|